Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis (original) (raw)

Abstract

In B-cell chronic lymphocytic leukemia (B-CLL) clonal chromosome aberrations are detected in approximately 40–50% of tumors when using conventional chromosome banding analysis. Most studies find trisomy 12 to be the most frequent chromosome aberration, followed by structural aberrations of the long arm of chromosomes 13 and 14. Trisomy 12 and the ”14q+” marker are associated with shorter survival times, while the patients with 13q abnormalities have a favorable outcome, similar to those with a normal karyotype. The development of molecular cytogenetic techniques has greatly improved our ability to detect chromosome aberrations in tumor cells. Using fluorescence in situ hybridization, chromosome aberrations can be detected not only in dividing cells but also in interphase nuclei, an approach referred to as interphase cytogenetics. The prevalence of specific aberrations in B-CLL is currently being reassessed by interphase cytogenetics. By far the most frequent abnormality are deletions involving chromosome band 13q14, followed by deletions of the genomic region 11q22.3-q23.1, trisomy 12, deletions of 6q21-q23, and deletions/mutations of the TP53 tumor suppressor gene at 17p13. The evaluation of the true incidence of these aberrations now provides the basis for more accurate correlations with clinical characteristics and outcome. Deletions/mutations of the TP53 gene have been shown to be associated with resistance to treatment and to be an independent marker for poor survival. 11q deletions have been associated with extensive nodal involvement, rapid disease progression, and short survival times. Whether trisomy 12, 13q14, and 6q deletions have a prognostic impact awaits further study. The application of these molecular cytogenetic techniques will also contribute to the identification of the pathogenetically relevant genes that are affected by the chromosome aberrations in B-CLL.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Medizinische Klinik and Poliklinik V, Universität Heidelberg, Hospitalstrasse 3, D-69115 Heidelberg, Germany, , , , , , DE
    H. Döhner, Stephan Stilgenbauer, Konstanze Döhner & Martin Bentz
  2. Abteilung ”Organisation komplexer Genome,” Deutsches Krebsforschungszentrum, Heidelberg, Germany, , , , , , DE
    Peter Lichter

Authors

  1. H. Döhner
    You can also search for this author inPubMed Google Scholar
  2. Stephan Stilgenbauer
    You can also search for this author inPubMed Google Scholar
  3. Konstanze Döhner
    You can also search for this author inPubMed Google Scholar
  4. Martin Bentz
    You can also search for this author inPubMed Google Scholar
  5. Peter Lichter
    You can also search for this author inPubMed Google Scholar

Additional information

Received: 2 February 1998 / Accepted: 31 March 1998

Rights and permissions

About this article

Cite this article

Döhner, H., Stilgenbauer, S., Döhner, K. et al. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis.J Mol Med 77, 266–281 (1999). https://doi.org/10.1007/s001090050350

Download citation